Zai Lab (ZLAB) Return on Invested Capital (2025 - 2026)

Zai Lab's (ZLAB) quarterly Return on Invested Capital came in at 0.0% in Q1 2026, down 11.74% quarter-over-quarter from 0.0% in Q4 2025.

Zai Lab (ZLAB) Return on Invested Capital (2025 - 2026) Analysis & Trends

Zai Lab has disclosed Return on Invested Capital across 2 years of filings, most recently posting 0.0% for Q1 2026.

  • Return on Invested Capital for Q1 2026 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
  • Return on Invested Capital came in at 0.0% for Q1 2026 at Zai Lab, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2025 to a low of 0.0% in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.01%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -0.01%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -0.01%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%